Skip to main content
2026 AAOMS 108th Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Ticketed <br><i>This session/event requires a ticket.</i>
Ticketed
This session/event requires a ticket.
In-person only<br><i>This session is offered in-person only.</i>
In-person only
This session is offered in-person only.
On-demand<br><i>On-demand session available beginning Sept. 28.</i>
On-demand
On-demand session available beginning Sept. 28.
Recorded<br><i>This session will be recorded and available beginning Oct. 19</i>
Recorded
This session will be recorded and available beginning Oct. 19
Sold Out<br><i>This ticketed session/event is sold out.</i>
Sold Out
This ticketed session/event is sold out.

Dentoalveolar

OMS and Other Dental Specialists

Residents

Session: Dentoalveolar Track: Hot-off-the-Press and Abstract Session

GP1d - A Prospective Split-Mouth Clinical Study: Comparison of the Effect of Lornoxicam and Etodolac on Postoperative Sequels Following Lower Third Molar Surgery

Thursday, October 1, 2026
4:00 PM - 4:10 PM PDT
Abstract: This study aims to compare the efficacy of 2 non-steroidal anti-inflammatory agents (NSAIDs), namely lornoxicam and etodolac for controlling pain, edema and trismus after removal of lower impacted third molars.

A total of 20 patients was included in the present study. Patients were randomly assigned either to the lornoxicam group (8 mg of lornoxicam) or to the etodolac group (400 mg of etodolac). The drugs prescribed were handed out immediately after tooth extraction. Postoperative pain was assessed using visual analog scale. Edema was evaluated using reference lines on the face. Trismus was assessed using a caliper at maximum mouth opening (mm).

There was no significant difference in postoperative pain, trismus, and edema between lornoxicam and etodolac group (P > .05).

Based on the results obtained in the present study, it has been verified that both lornoxicam and etodolac were adequately effective in the management of pain following third molar surgery. Lornoxicam and etodolac had similar impacts on pain, edema, and trismus after impacted lower third molar surgical extractions.
VAS scores between study groups for pain (P > .05)
The study was performed according to CONSORT chart
Measurement of Edema The same examiner performed all clinical measurements prior to surgery (baseline) as well as at 48th and 168th for edema. Facial edema was evaluated by measuring three lines using a flexible plastic tape. Line 1-2: The most posterior point of the tragus to the most lateral point of the lip commissure. Line 2-3: The most inferior point angle of the mandible to the most lateral point of the lip commissure. Line 3-4: The lateral canthus of the eye to the most inferior point angle of the mandible